Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ETHZilla Corp Director's Dealing 2021

Apr 9, 2021

33039_dirs_2021-04-09_855e8826-bd84-4d43-842c-1a92b743f726.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: 180 Life Sciences Corp. (ATNF)
CIK: 0001690080
Period of Report: 2021-04-07

Reporting Person: Rothbard Jonathan B. (Chief Scientific Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-04-07 Common Stock A 24307 $6.14 Acquired 560449 Direct

Footnotes

F1: Issued in consideration for accrued compensation due for services rendered as Chief Scientific Officer of the Issuer. Granted under the registrant's 2020 Omnibus Incentive Plan. Exempt from Section 16(b) pursuant to Rule 16b-3.